United States · FDA National Drug Code directory
Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43353-717_80c4cb36-638f-4d42-aa92-c5428ba5c547
- Product NDC
- 43353-717
- Form
- TABLET
- Composition / generic term
- Hydrochlorothiazide
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 19800107
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROCHLOROTHIAZIDE — 50 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 9000 TABLET in 1 BOTTLE (43353-717-09) · 43353-717-09
- 30 TABLET in 1 BOTTLE (43353-717-30) · 43353-717-30
- 45 TABLET in 1 BOTTLE (43353-717-45) · 43353-717-45
- 60 TABLET in 1 BOTTLE (43353-717-53) · 43353-717-53
- 90 TABLET in 1 BOTTLE (43353-717-60) · 43353-717-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →